[HTML][HTML] Clinical and radiographic features of a cohort of adult and pediatric subjects in the Pacific Northwest with myelin oligodendrocyte glycoprotein antibody …

K Martin, P Srikanth, A Kanwar, J Falardeau… - Multiple sclerosis and …, 2024 - Elsevier
Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is
a newly described clinical entity comprised of isolated or recurrent attacks of optic neuritis …

“Peppering the pons”: CLIPPERS or myelin oligodendrocyte glycoprotein associated disease?

AZ Obeidat, AN Block, SI Hooshmand - Multiple Sclerosis and Related …, 2021 - Elsevier
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to
steroids (CLIPPERS) is a distinct pathologic entity of unknown etiology. Here, we describe …

Efficacy and safety of immunosuppressive therapy in myelin oligodendrocyte glycoprotein antibody–associated disease: a systematic review and meta-analysis

QL Lai, YX Zhang, MT Cai, Y Zheng… - Therapeutic …, 2021 - journals.sagepub.com
Background: A considerable number of patients with myelin oligodendrocyte glycoprotein
antibody–associated disease (MOGAD) will experience a relapse, but the effect of …

Myelin oligodendrocyte glycoprotein (MOG) antibodies in a patient with glioblastoma: red flags for false positivity

M Amin, MA Mays, D Polston, EP Flanagan… - Journal of …, 2021 - Elsevier
We present a patient with positive medium titer MOG-IgG and progressive neurological
decline whose clinical and radiological phenotype were not consistent with a MOG-IgG …

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

AB Wolf, J Palace, JL Bennett - Current Treatment Options in Neurology, 2023 - Springer
Purpose of review Myelin oligodendrocyte glycoprotein antibody-associated disease
(MOGAD) is a rare inflammatory disorder of the central nervous system that affects both …

Progressive myelopathy in myelin oligodendrocyte glycoprotein antibody-associated disease: a new mimicker of progressive multiple sclerosis?

SB Marcucci, M Elkasaby, R Walch… - Multiple Sclerosis and …, 2021 - Elsevier
Background MOG-IgG-associated disease (MOGAD) in adults typically presents as a
monophasic or relapsing optic, spinal, or opticospinal neuroinflammatory syndrome. Current …

Tocilizumab treatment in MOGAD: a case report and literature review

G Schirò, S Iacono, M Andolina, A Bianchi… - Neurological …, 2024 - Springer
Myelin oligodendrocyte glycoprotein-immunoglobulin G associated disease (MOGAD) is an
autoimmune demyelinating disorder of the central nervous system (CNS) which usually …

Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: the difficulty of predicting relapses

SE Epstein, S Levin, K Onomichi, C Langston… - Multiple sclerosis and …, 2021 - Elsevier
Background While many patients with myelin oligodendrocyte glycoprotein antibody-
mediated disease (MOG-AD) will have a monophasic course, 30-80% of patients will …

[PDF][PDF] Monoclonal antibody therapies for aquaporin-4-immunoglobulin G-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein …

N Tisavipat, HY Juan, JJ Chen - Saudi Journal of Ophthalmology, 2023 - journals.lww.com
Monoclonal antibody therapies mark the new era of targeted treatment for relapse
prevention in aquaporin-4 (AQP4)-immunoglobulin G (IgG)-positive neuromyelitis optica …

Chronic relapsing inflammatory optic neuropathy (CRION)

L Mukharesh, VP Douglas… - Current Opinion in …, 2021 - journals.lww.com
CRION is an inflammatory optic neuropathy that is characterized by a chronic and relapsing
course, that is characterized by pain associated with subacute vision loss. It is favorably …